Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer interface (BCI).

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

“The Bee Sting” by Paul Murray. The plot builds slowly to a breathtaking crescendo. But the real genius is in how it’s told: ...

Windows went on sale 40 years ago. Here's the whole history of the operating system, from Windows 1 to 11 and everything in between.

Internxt is a GDPR-compliant cloud storage with AES-256 encryption. It offers a free 1 GB plan and enables encrypted sharing ...

Seven packages published on the Node Package Manager (npm) registry use the Adspect cloud-based service to separate ...

Japanese operator accelerates trial of next-generation mobile technologies claiming trial has resulted in throughput improving by up to 100% under real-world outdoor conditions.

After more than a month of rumors and feverish speculation — including Polymarket wagering on the release date — Google today ...